Testimony by Jennifer Schneider, MD to the California Senate Health Committee re AB 926
By Jennifer Schneider, MD
| 06. 16. 2013
June 12, 2013
My name is Jennifer Schneider. I’m an Internal Medicine physician and the mother of a Stanford student egg donor. I would support AB 926 if it did what its authors claimed, but it does not.
I’m concerned about increasing the number of women who go through egg donation because of what happened to my daughter. Jessica was an honors student – 6 feet tall, athletic, beautiful, artistic, a non-smoking vegetarian. [Show her photo] One day, she phoned to tell me she decided donate her eggs. She said, “Don’t worry Mom. They told me there’s a small risk of bleeding and infection, but otherwise they haven’t found any problems.” So she went one cycle without problems; in fact, she did it twice more in the next few months.
About seven years later, Jessica was diagnosed with colon cancer, a disease no one in my family had had. Two years later, after chemotherapy, surgery, and radiation, she died. She was 31.
After her death I published a 2008 paper in Fertility and Sterility, the official journal of the American Society for...
Related Articles
By Carly Mallenbaum, Axios [cites Emily Galpern] | 03.29.2026
More Americans are turning to surrogacy to build their families, as the practice becomes more common and more publicly discussed.
Why it matters: As surrogacy becomes more visible and accessible, ethical, legal and cultural tensions become harder to ignore...
By Carly Mallenbaum, Axios [cites Surrogacy360] | 03.29.2026
Without a federal law, surrogacy in the U.S. is governed by a patchwork of state regulations/
Why it matters: Confusing, varied local rules can determine everything from whether agreements are legally binding to who is recognized as a parent at...
By Judd Boaz and Elise Kinsella, ABC News | 03.17.2026
By Ryan Cross, Endpoints News | 03.24.2026
Cathy Tie has an audacity more typical of a tech startup founder than a biotech executive. She dropped out of college to start a genetic screening company and later founded a telemedicine startup. The 29-year-old has been on two Forbes...